Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCooper Financial Group
Latest Disclosed Ownership8,124 shares
Latest Disclosed Value $ 2,858,376
Cooper Financial Group reports 6.35% increase in ownership of AMGN / Amgen Inc.

On April 7, 2026 - Cooper Financial Group filed a 13F-HR form disclosing ownership of 8,124 shares of Amgen Inc. (MX:AMGN) valued at $2,858,376 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 7,639 shares of Amgen Inc.. This represents a change in shares of 6.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F AMGEN COM 031162100 8,124 485 6.35 2,858 14.32 0.2889
2026-01-08 2025-12-31 13F AMGEN COM 031162100 7,639 -459 -5.67 2,500 9.41 0.2661
2025-10-07 2025-09-30 13F AMGEN COM 031162100 8,098 -160 -1.94 2,285 -0.87 0.2529
2025-07-18 2025-06-30 13F AMGEN COM 031162100 8,258 -76 -0.91 2,306 -11.21 0.2712
2025-05-12 2025-03-31 13F AMGEN COM 031162100 8,334 -10 -0.12 2,597 19.41 0.3420
2025-01-13 2024-12-31 13F AMGEN COM 031162100 8,344 442 5.59 2,175 -14.61 0.2619
2024-11-14 2024-09-30 13F AMGEN COM 031162100 7,902 216 2.81 2,546 6.04 0.3305
2024-07-15 2024-06-30 13F AMGEN COM 031162100 7,686 -732 -8.70 2,402 0.33 0.3531
2024-04-11 2024-03-31 13F AMGEN COM 031162100 8,418 -60 -0.71 2,393 -1.97 0.3934
2024-01-16 2023-12-31 13F AMGEN COM 031162100 8,478 490 6.13 2,442 13.75 0.4440
2023-10-13 2023-09-30 13F AMGEN COM 031162100 7,988 -68 -0.84 2,147 20.02 0.5161
2023-07-07 2023-06-30 13F AMGEN COM 031162100 8,056 -113 -1.38 1,789 -9.42 0.4435
2023-05-11 2023-03-31 13F AMGEN COM 031162100 8,169 362 4.64 1,975 -3.71 0.5321
2023-01-13 2022-12-31 13F AMGEN COM 031162100 7,807 37 0.48 2,050 17.08 0.6261
2022-10-13 2022-09-30 13F AMGEN COM 031162100 7,770 139 1.82 1,751 -5.71 0.6301
2022-07-11 2022-06-30 13F AMGEN COM 031162100 7,631 -136 -1.75 1,857 -1.12 0.6744
2022-04-25 2022-03-31 13F/A-1 AMGEN COM 031162100 7,767 180 2.37 1,878 10.02 0.7133
2022-04-12 2022-03-31 13F AMGEN COM 031162100 7,767 180 1,878 0.7127
2022-02-11 2021-12-31 13F AMGEN COM 031162100 7,587 -769 -9.20 1,707 -3.94 0.6444
2021-10-06 2021-09-30 13F AMGEN COM 031162100 8,356 202 2.48 1,777 -10.61 0.3686
2021-07-12 2021-06-30 13F AMGEN COM 031162100 8,154 266 3.37 1,988 1.27 0.4043
2021-05-17 2021-03-31 13F AMGEN COM 031162100 7,888 -1,052 -11.77 1,963 -4.52 0.4433
2021-02-16 2020-12-31 13F AMGEN COM 031162100 8,940 1,250 16.25 2,056 5.22 0.4193
2020-10-09 2020-09-30 13F AMGEN COM 031162100 7,690 -301 -3.77 1,954 3.66 0.5641
2020-07-15 2020-06-30 13F AMGEN COM 031162100 7,991 2,383 42.49 1,885 65.79 0.6101
2020-05-15 2020-03-31 13F AMGEN COM 031162100 5,608 453 8.79 1,137 -8.53 0.4739
2020-01-07 2019-12-31 13F AMGEN COM 031162100 5,155 -92 -1.75 1,243 22.46 0.4975
2019-10-08 2019-09-30 13F AMGEN COM 031162100 5,247 1,003 23.63 1,015 29.80 0.4577
2019-07-08 2019-06-30 13F AMGEN COM 031162100 4,244 925 27.87 782 23.93 0.3792
2019-05-15 2019-03-31 13F AMGEN COM 031162100 3,319 -757 -18.57 631 -20.53 0.3476
2019-01-17 2018-12-31 13F AMGEN COM 031162100 4,076 4,076 794 0.5382
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.